Abstract Submission

Submit Full Paper

Deadline: 22nd May 2023

Call for Abstract

The Scientific Committee welcomes the submission of scientific abstracts. Authors are invited to submit abstracts in the following areas of interest:

  1. Medical Imaging
  2. Forensics Imaging
  3. Informatics Technology
  4. Interventional Radiology
  5. Molecular Imaging / Nuclear Medicine
  6. Medical Physics
  7. Paediatrics Radiology
  8. Radiation Therapy
  9. Ultrasound Imaging
  10. Education
  11. Workforce
  12. Artificial Intelligence

All abstracts are to be submitted online. Final forms of presentation can be in any of the following formats: -

  1. Oral presentation
  2. E-Poster presentation

Each participant will only be able to submit 2 abstracts.

All abstracts are to be reviewed by the Scientific Committee. The Committee reserves the right to decide on the final form of presentation.

The Presenting Author of successful abstracts must complete his/her registration for the congress as a delegate before 30th July 2023 and present his/her work during the congress.


Abstract Guidelines:

  1. The abstract must be submitted in English.
  2. Please specify the abstract title.
  3. The title must be in capital letters and is limited to a maximum of 640 characters.
  4. Please provide the co-authors’ details (names, affiliations). Ensure that all author's information is included and entered correctly.
  5. Please provide the abstract body text. The abstract body is limited to 250 words, approximately 1600 characters.
  6. According to the table below, the body must be divided into sections related to types of abstracts.

Format of content to follow: -

Studies / Research Case Report Education Exhibit
Objective Introduction Learning Objective
Materials & Methods Not Applicable Background
Results Report Findings and/or Procedure Details
Conclusion Conclusion Conclusion
  1. The Objective and Conclusion must be consistent with those in the main text and should use the exact wording. The Results should present the study’s primary outcomes using specific numerical data (e.g., absolute numbers and/or rates) with appropriate indicators of statistical uncertainty, such as 95% confidence intervals or p-values. P values should never be presented alone without the actual data that are being compared. Do not use reference citations in the abstract. Abbreviations should be minimised and, if used, must be defined within the abstract by full terminology followed by the abbreviation in parenthesis.
  2. Use the original term for medical terms such as proper nouns, generic names of medicines, and units of measurement terms. The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where first used, followed by the acronym or abbreviation in parentheses. Measurements and laboratory values should follow the International System of Units (SI).
  3. Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study involved an exclusive population, for example, in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
  4. The names and locations (city and state or country) of equipment manufacturers and non-generic drugs should be given.
  5. Ensure that all changes, corrections and proofreading are done before submission.


Notification of Acceptance

  1. Review of abstracts will take 4 to 6 weeks from the abstract submission deadline.
  2. The Scientific Committee will review all abstracts. The Committee reserves the right to select the abstracts and assign the sessions and final format of the presentation. The decision of the Committee is final.
  3. Results will be announced via email by 15th June 2023.
  4. All accepted abstract-presenting authors MUST complete his/her registration for the congress as a delegate before 30th July 2023 and present his/her work during the congress.



We are pleased to announce that selected papers will be published in Scopus-indexed journals.

The conference book proceeding will be ‎published with an ISBN number and indexed by SCOPUS.

A selection of papers will be published as Journal Publication in indexed journal subject to further developments to match the journal ‎requirements.

Kindly be advised that the journals details & APC fees will be announced soon.



The organisers of this event and AACRT take no responsibility for any published abstracts submitted. Any issues or errors arising from the abstracts are solely the authors’ responsibility.

By submitting his/her/their work, the Author(s) consent to the publication of the abstracts in journals chosen and transfer and assign to the Congress and AACRT the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press releases. Author(s) represents and warrants that he/she/they is/ are the sole Author (s) of the work and that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary or personal right of any third party. If the work is not original, the Author(s) should reference the source and ensure all relevant permission and/or authorisation to re-use has been obtained.

If you have questions, please email us at aacrt2023@gmail.com.